Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Multiple cellular mechanisms related to cyclin A1 in prostate cancer invasion and metastasis.

Wegiel B, Bjartell A, Tuomela J, Dizeyi N, Tinzl M, Helczynski L, Nilsson E, Otterbein LE, Härkönen P, Persson JL.

J Natl Cancer Inst. 2008 Jul 16;100(14):1022-36. doi: 10.1093/jnci/djn214. Epub 2008 Jul 8.

2.

Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.

Chung LW, Baseman A, Assikis V, Zhau HE.

J Urol. 2005 Jan;173(1):10-20. Review.

PMID:
15592017
3.

NF-kappaB activation in human prostate cancer: important mediator or epiphenomenon?

Suh J, Rabson AB.

J Cell Biochem. 2004 Jan 1;91(1):100-17. Review.

PMID:
14689584
4.

Androgen receptor and prostate cancer invasion.

Bonaccorsi L, Muratori M, Carloni V, Zecchi S, Formigli L, Forti G, Baldi E.

Int J Androl. 2003 Feb;26(1):21-5. Review.

PMID:
12534934
5.

Biomarkers associated with prostate cancer progression.

Zhau HE, Pisters LL, Hall MC, Zhao LS, Troncoso P, Pollack A, Chung LW.

J Cell Biochem Suppl. 1994;19:208-16. Review.

PMID:
7529853
6.
7.

[Molecular biology in the prostate neoplasia].

Brum IS, Spritzer PM, Brentani MM.

Arq Bras Endocrinol Metabol. 2005 Oct;49(5):797-804. Epub 2006 Jan 23. Review. Portuguese.

8.

Overexpression of G protein-coupled receptors in cancer cells: involvement in tumor progression.

Li S, Huang S, Peng SB.

Int J Oncol. 2005 Nov;27(5):1329-39. Review.

PMID:
16211229
9.

Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis.

Ii M, Yamamoto H, Adachi Y, Maruyama Y, Shinomura Y.

Exp Biol Med (Maywood). 2006 Jan;231(1):20-7. Review.

PMID:
16380641
10.

Mechanisms of prostate tumorigenesis: roles for transcription factors Nkx3.1 and Egr1.

Abdulkadir SA.

Ann N Y Acad Sci. 2005 Nov;1059:33-40. Review.

PMID:
16382041
11.

E- and A-type cyclins as markers for cancer diagnosis and prognosis.

Yasmeen A, Berdel WE, Serve H, Müller-Tidow C.

Expert Rev Mol Diagn. 2003 Sep;3(5):617-33. Review.

PMID:
14510182
12.

Molecular markers and determinants of prostate cancer metastasis.

Gopalkrishnan RV, Kang DC, Fisher PB.

J Cell Physiol. 2001 Dec;189(3):245-56. Review.

PMID:
11748582
13.

Prostate cancer progression and surrounding microenvironment.

Alberti C.

Int J Biol Markers. 2006 Apr-Jun;21(2):88-95. Review.

PMID:
16847811
14.

Role of maspin in tumor metastasis and angiogenesis.

Schaefer JS, Zhang M.

Curr Mol Med. 2003 Nov;3(7):653-8. Review.

PMID:
14601639
15.

Molecular markers of prostate cancer outcome.

Quinn DI, Henshall SM, Sutherland RL.

Eur J Cancer. 2005 Apr;41(6):858-87. Review.

PMID:
15808955
16.

Expression of the chemokine receptor CCR7 in prostate cancer presenting with generalized lymphadenopathy: report of a case, review of the literature, and analysis of chemokine receptor expression.

Heresi GA, Wang J, Taichman R, Chirinos JA, Regalado JJ, Lichtstein DM, Rosenblatt JD.

Urol Oncol. 2005 Jul-Aug;23(4):261-7. Review.

PMID:
16018941
17.

Blood vessels are regulators of growth, diagnostic markers and therapeutic targets in prostate cancer.

Lissbrant IF, Lissbrant E, Damber JE, Bergh A.

Scand J Urol Nephrol. 2001 Dec;35(6):437-52. Review.

PMID:
11848422
18.

Metastasis-related genes in prostate cancer.

Bangma CH, Nasu Y, Ren C, Thompson TC.

Semin Oncol. 1999 Aug;26(4):422-7. Review.

PMID:
10482184
19.

Molecular chemoprevention by selenium: a genomic approach.

El-Bayoumy K, Sinha R.

Mutat Res. 2005 Dec 11;591(1-2):224-36. Epub 2005 Aug 15. Review.

PMID:
16099479
20.

Apoptosis in male germ cells in response to cyclin A1-deficiency and cell cycle arrest.

Salazar G, Liu D, Liao C, Batkiewicz L, Arbing R, Chung SS, Lele K, Wolgemuth DJ.

Biochem Pharmacol. 2003 Oct 15;66(8):1571-9. Review.

PMID:
14555236

Supplemental Content

Support Center